Skip to main content

Aviwell

Category: AI in Agriculture

A deep-tech animal nutrition company developing AI-driven microbiome solutions to improve animal health, performance, and sustainable food production. Aviwell was founded in 2016. The company is led by Chandra Mouli Ramani. Based in Toulouse, France. Team size: 11-50. Total funding raised: €20.0M. Latest round: Series A. Key investors include ["Blue Revolution Fund","Elaia","MFS Investment Management","Blast.Club","SWEN Capital Partners","European Innovation Council (EIC) Fund","BPI France"].

Founded
2016
Headquarters
Toulouse, France
Team size
11-50
Total funding
€20.0M

Value proposition

Provides natural, antibiotic-free alternatives to traditional growth promoters, improving animal welfare and reducing environmental impact through science-based microbiota insights.

Products and solutions

["Aneto™ Microbiome Discovery Platform","Natural Foie Gras (non-gavage/no force-feeding solution)","Direct Fed Microbials (DFM) for poultry and swine","Sustainable aquaculture nutrition solutions"]

Unique value

Combines 30 years of gut-brain axis research with AI to trigger natural physiological processes, such as fat accumulation in liver without force-feeding (gavage).

Target customer

Livestock producers (poultry, swine, aquaculture), animal feed manufacturers, and ethical food retailers.

Industries served

["AgTech","Biotechnology","Animal Nutrition","Food & Beverage"]

Technology advantage

Utilizes proprietary biostatistical algorithms and 'Native and Adaptive Biomimicry' to identify specific bacterial strains that optimize metabolic health and growth naturally.

How they differentiate

Focuses on the gut-brain axis and 'Native and Adaptive Biomimicry' to trigger natural physiological processes, such as fat accumulation without force-feeding (non-gavage), rather than just general probiotic supplementation.

Main competitors

["BiomEdit","Native Microbials","Proteon Pharmaceuticals"]

Key partnerships

["Microba Life Sciences (Strategic discovery partnership)","Toulouse White Biotechnology (TWB) / INRAE (Research and hosting)","Blue Revolution Fund (Aquaculture focus)","Elaia and MFS Investment Management (Financial partners)"]

Notable customers

["Microba Life Sciences (Strategic Partner)","Toulouse White Biotechnology (TWB)","Confidential major poultry and aquaculture producers"]

Major milestones

["Successfully developed 'Natural Foie Gras' without force-feeding (gavage) as a proof of concept for metabolic control.","Launched the Aneto™ Microbiome Discovery Platform.","Secured €9M Seed funding in June 2023.","Closed €11M Series A funding in March 2025 to accelerate commercialization."]

Growth metrics

Expanded from poultry-specific solutions to swine and aquaculture; scaled team to 11-50 employees following Series A.

Market positioning

Deep-tech AgTech/Biotech pioneer specializing in AI-driven microbiome discovery for sustainable livestock and aquaculture.

Geographic focus

Europe (France), North America, and Southeast Asia (Aquaculture markets).

Patents and IP

Proprietary IP portfolio based on 30 years of research from INSERM and INRAE, covering specific microbial strains and discovery methodologies.

About Chandra Mouli Ramani

Chandra Mouli Ramani is a seasoned executive with over 30 years of leadership experience across the technology, biotech, and data science sectors. Before leading Aviwell, he served as the Chair of the Board of Directors at Horsepower Technologies, a medical device and SaaS startup. He was also a Founding Partner at Open Learning Exchange (OLE) and has held various senior executive roles in both startups and Fortune 500 companies, specializing in scaling deep-tech innovations.

Official website: